A Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

by | Jan 2, 2026 | Clinical Trials | 0 comments

​ Conditions: Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Interventions: Biological: LP-003 Injection; Biological: Placebo of LP-003

Sponsors: Longbio Pharma

Not yet recruiting Conditions: Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Interventions: Biological: LP-003 Injection; Biological: Placebo of LP-003
Sponsors: Longbio Pharma
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *